These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17213557)

  • 1. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe.
    Soldan K; Dillner J
    Euro Surveill; 2006 Nov; 11(11):E061123.3. PubMed ID: 17213557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 3. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide impact of the human papillomavirus vaccine.
    Hakim AA; Dinh TA
    Curr Treat Options Oncol; 2009 Apr; 10(1-2):44-53. PubMed ID: 19387841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do you approve of spending $300 million on HPV vaccination?: no.
    Lippman A; Boscoe M; Scurfield C
    Can Fam Physician; 2008 Feb; 54(2):175, 177, 179, 181. PubMed ID: 18272623
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination against human papillomavirus.
    Mello CF
    Einstein (Sao Paulo); 2013 Dec; 11(4):547-9. PubMed ID: 24488402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomavirus vaccine for women, and for men?
    Hidalgo Tenorio C
    Med Clin (Barc); 2019 Apr; 152(7):264-265. PubMed ID: 30591274
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
    Stanley M; Dull P
    Vaccine; 2018 Aug; 36(32 Pt A):4759-4760. PubMed ID: 29754700
    [No Abstract]   [Full Text] [Related]  

  • 12. Human papillomavirus vaccine.
    Miller NB; Raychaudhuri G; Toerner JG
    N Engl J Med; 2007 Sep; 357(11):1154-5; author reply 1155-6. PubMed ID: 17855679
    [No Abstract]   [Full Text] [Related]  

  • 13. [The first vaccine for prevention of cervix cancer and other human papillomavirus related diseases gets a positive evaluation by the European Drug Authority].
    Kinderkrankenschwester; 2006 Sep; 25(9):389-90. PubMed ID: 17017592
    [No Abstract]   [Full Text] [Related]  

  • 14. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 15. No Vacillation on HPV Vaccination.
    Sipp D; Frazer IH; Rasko JEJ
    Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a theory-guided storytelling narrative intervention to improve HPV vaccination behavior: Save our daughters from cervical cancer.
    Lee H; Kim M; Allison J; Kiang P
    Appl Nurs Res; 2017 Apr; 34():57-61. PubMed ID: 28342625
    [No Abstract]   [Full Text] [Related]  

  • 17. Mandating HPV vaccination: what are the arguments?
    Smith CM
    J Christ Nurs; 2008; 25(2):74-80; quiz 81-2. PubMed ID: 18401926
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
    Herrero R
    J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
    [No Abstract]   [Full Text] [Related]  

  • 20. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.